LOSARTAN, A COMMON DRUG USED TO TREAT HYPERTENSION, IS BEING EVALUATED FOR ITS EFFACY AGAINST COVID-
UNIVERSITY OF MINNESOTA COVID-19 CLINICAL TRIALS
COVID-19 is a new disease caused by the coronavirus. Doctors do not currently have an approved way of treating or curing the disease.
Clinical trials help doctors determine if a medication is a safe and effective treatment for people with this disease. The University of Minnesota is conducting several clinical trials to test whether different medications can help cure, treat, or reduce the severity of COVID-19. We need people like you to participate in a trial and help us learn how to help. Your participation is critical in helping doctors understand what medicines are safe to use for our families and friends so that we can all return to our normal lives. You do not have to live in Minnesota to participate; anyone in the United States can contact us to learn more.
The University of Minnesota will be testing a number of therapies to determine their safety and effectiveness. See descriptions below to determine which trial may be right for you. Progress Updates If you’re interested in updates on our clinical trials, please submit an email address here.
PROTECTION/PREVENTION You are eligible if you are a healthcare worker in a setting that is high risk for exposure to COVID-19. PI: Radha Rajasingham, MD Go to clinical trial #1 TREATMENT You are eligible if you have a positive laboratory test for COVID-19 and are age 18 or older. PIs: Christopher Tignanelli, MD, and Mike Puskarich, MD Go to clinical trial #2 You are eligible if you have been closely exposed to a person with confirmed/test-proven COVID-19 disease within 4 days of enrolling, AND live in the same household as this person or are a healthcare worker. Or Currently diagnosed with confirmed/test-proven COVID-19 disease within 4 days of symptom onset, OR are a household contact or healthcare worker with a confirmed/test-proven COVID-19 contact, and are currently within the first 4 days of experiencing compatible symptoms with pending/unavailable testing. PI: David Boulware, MD, MPH Go to clinical trial #3 REDUCING SEVERITY You are eligible if you have been admitted to a hospital with symptoms suggestive of COVID-19 infection. PI: Susan Kline, MD, MPH Go to clinical trial #4 You must meet eligibility requirements in order to participate in any clinical trial.